Literature DB >> 12082377

Refractory chylothorax in hepatic cirrhosis: successful treatment by transjugular intrahepatic portosystemic shunt.

Olivier Vignaux1, Hervé Gouya, Bertrand Dousset, Elisabeth Mazuir, Catherine Buffet, Yvon Calmus, Paul Legmann.   

Abstract

Patients with cirrhosis and portal hypertension have increased thoracic duct lymph flow. Correction of portal hypertension is associated with decreases in thoracic duct flow. The authors present a case of rapid resolution of refractory chylothorax caused by thoracic duct injury proven by lymphangiography and helical CT scan in a patient with cirrhosis of the liver by using a transjugular intrahepatic portosystemic shunt to decrease portal pressure and thereby reduce thoracic duct lymph flow.

Entities:  

Mesh:

Year:  2002        PMID: 12082377     DOI: 10.1097/00005382-200207000-00010

Source DB:  PubMed          Journal:  J Thorac Imaging        ISSN: 0883-5993            Impact factor:   3.000


  3 in total

1.  Transjugular intrahepatic portosystemic shunt in refractory chylothorax due to liver cirrhosis.

Authors:  Philipp Lutz; Holger Strunk; Hans Heinz Schild; Tilman Sauerbruch
Journal:  World J Gastroenterol       Date:  2013-02-21       Impact factor: 5.742

Review 2.  Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update.

Authors:  Sasidharan Rajesh; Tom George; Cyriac Abby Philips; Rizwan Ahamed; Sandeep Kumbar; Narain Mohan; Meera Mohanan; Philip Augustine
Journal:  World J Gastroenterol       Date:  2020-10-07       Impact factor: 5.742

Review 3.  Strategic Approach to Massive Chylous Leakage after Neck Dissection.

Authors:  Geng-He Chang; Chih-Yao Lee; Yao-Te Tsai; Chi-Cheng Fang; Ku-Hao Fang; Ming-Shao Tsai; Cheng-Ming Hsu; Chih-Wei Luan; Chang-Cheng Chang
Journal:  Healthcare (Basel)       Date:  2021-03-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.